Most cited papers from HemoGenix (United States)

HemoGenix (United States)

What are the most cited papers from HemoGenix (United States)?

The most cited paper from HemoGenix (United States) is "Autocrine transforming growth factor-β regulation of hematopoiesis: many outcomes that depend on the context" (Francis W. Ruscetti, Salem M. Akel, Stephen H. Bartelmez, 2005), with 111 citations. Next come "Validation and Development of a Predictive Paradigm for Hemotoxicology Using a Multifunctional Bioluminescence Colony-Forming Proliferation Assay" (52) and "Emerging approaches in predictive toxicology" (37).

Published TypeFieldAccess

Showing 24 of 24 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Autocrine transforming growth factor-β regulation of hematopoiesis: many outcomes that depend on the context Francis W. Ruscetti, Salem M. Akel, Stephen H. Bartelmez · Oncogene	26 Aug 2005	111
2	Validation and Development of a Predictive Paradigm for Hemotoxicology Using a Multifunctional Bioluminescence Colony-Forming Proliferation Assay Ivan N. Rich, Karen M. Hall · Toxicological Sciences Open access	7 Jul 2005	52
3	Emerging approaches in predictive toxicology Luoping Zhang, Cliona M. McHale, Nigel Greene et al. · Environmental and Molecular Mutagenesis Open access	9 Jul 2014	37
4	Improving Quality and Potency Testing for Umbilical Cord Blood: A New Perspective Ivan N. Rich · Stem Cells Translational Medicine Open access	9 Jul 2015	25
5	In vitro hematotoxicity testing in drug development: a review of past, present and future applications. Ivan N. Rich · PubMed	2003	20
6	Detecting primitive hematopoietic stem cells in total nucleated and mononuclear cell fractions from umbilical cord blood segments and units John B. Patterson, Cally H. Moore, Emily Palser et al. · Journal of Translational Medicine Open access	17 Mar 2015	19
7	High-throughputin vitrohemotoxicity testing andin vitrocross-platform comparative toxicity Ivan N. Rich · Expert Opinion on Drug Metabolism & Toxicology	Apr 2007	18
8	Development of a novel assay to evaluate the functional potential of umbilical cord blood progenitors Jo‐Anna Reems, Karen M. Hall, Luladay H. Gebru et al. · Transfusion Open access	10 Jan 2008	17
9	Measuring Stem Cell Circadian Rhythm William J.M. Hrushesky, Ivan N. Rich · Methods in molecular biology Book chapter	29 Oct 2014	10
10	Measurement of Hematopoietic Stem Cell Proliferation, Self-Renewal, and Expansion Potential Ivan N. Rich · Methods in molecular biology Book chapter	29 Oct 2014	7
11	Measuring the Potency of a Stem Cell Therapeutic Holli Harper, Ivan N. Rich · Methods in molecular biology Book chapter	29 Oct 2014	5
12	Immunomodulatory effects of Purion processed human amniotic membrane allografts in vitro Sarah E. Moreno, Joseph A Mikulin, Michelle Massee et al. · Journal of Inflammation Open access	16 Dec 2025	1
13	Primitive Hematopoietic Stem / Progenitor Cell Proliferation Detected by HALO (an ATP-Based Assay System) Coupled with Flow Cytometric Phenotypic Analysis. Stephen H. Bartelmez, Karen M. Hall, Ivan N. Rich · Blood	16 Nov 2004	1
14	Short Primer in Stem Cell Biology Ivan N. Rich · Methods in molecular biology Book chapter	29 Oct 2014	1
15	Tissue Engineering Ivan N. Rich · Elsevier eBooks Book chapter	6 Dec 2014	1
16	A Stem Cell Population Capable of Producing Both Lympho- and Hematopoietic Cells Can Be Used To Detect Increased Sensitivity and Residual Stem Cell Damage after Initial Drug Administration. Ivan N. Rich, Karen M. Hall · Blood	16 Nov 2005	0
17	Measurement of Stem Cell Potency, Assessment of Acceptance Limits for Release Criteria and Prediction of Umbilical Cord Blood Engraftment Using a Replacement for the Colony-Forming Cell Assay Ivan N. Rich, Karen M. Hall, Holli Harper et al. · Blood	16 Nov 2008	0
18	Quality Control of Cell Processing and Cord Blood Storage Using HALO To Measure Proliferative Potential of Stem and Progenitor Cells. Ivan N. Rich, Karren Hall, Stephen H. Bartelmez · Blood	16 Nov 2004	0
19	Development of a Potency Assay for Umbilical Cord Blood. Jo Anna Reems, Karen M. Hall, Luluday H. Gebru et al. · Blood	16 Nov 2006	0
20	Prediction of Lympho-Hematopoietic Regulatory Responses to Different Agents Using a 7-Population In Vitro Proliferation Assay. Ivan N. Rich, Karen M. Hall · Blood	16 Nov 2005	0
21	Proliferation Versus Differentiation: The Effect of Growth Factor Stimulation Detected by HALO. Ivan N. Rich, Karren Hall, Stephen H. Bartelmez · Blood	16 Nov 2004	0
22	The Biology And Measurement Of Hematopoietic Stem Cell Potency Ivan N. Rich, Karen M. Hall, Holli Harper · Transplantation and Cellular Therapy Open access	Feb 2010	0
23	The total nucleated cell (TNC) fraction and dye exclusion viability cannot be used to measure the quality and potency of umbilical cord blood cells in segments and units Ivan N. Rich, John B. Patterson, Cally H. Moore et al. · Cytotherapy	27 Apr 2015	0
24	A Stem Cell Potency, Quality And Release (PQR) Assay For Umbilical Cord Blood That Is Compliant With Regulatory Guidelines Ivan N. Rich, Karen M. Hall, Holli Harper · Transplantation and Cellular Therapy Open access	Feb 2010	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.